Demna has just revealed his first collection for Gucci, shared ahead of its Spring 20265 show during Milan Fashion Week. Titled “La Famiglia,” the imagery finds models including Alex Consani and Lila ...

OpenAI has added a setting that lets Plus, Pro and Business users control how quickly GPT-5 with Thinking responds. The option appears in the message composer on the web and lets users trade off ...

Myths about birth control have long proliferated in the US (thanks in part to the abysmal state of sex ed), but recent events have amplified their spread—namely, the rise of influencers sharing ...

Meta has launched its advanced smart glasses, the Meta Ray-Ban Display, priced at $799, featuring a built-in screen and gesture controls. Updated Ray-Ban Meta Gen 2 glasses offer improved battery and ...

Amid the many twists and turns in the high-profile inheritance battle over late industrialist Sunjay Kapur’s assets, a shocking revelation has been made by sources close to the actress. While the ...

Marico Limited has announced the acquisition of the remaining 46.02% stake in HW Wellness Solutions Pvt. Ltd., the parent company of health foods brand True Elements, for up to Rs 138 crore. The move ...

The way we use the internet has changed. It’s no longer just about browsing websites, it’s where we read, learn, work, and even get answers from AI assistants. Recognizing this shift, Perplexity has ...

First chemotherapy-free trial combining ANKTIVA, an IL-15 agonist, natural killer (NK) cell therapy, and Optune immune-stimulating device for patients with glioblastoma (GBM) brain tumors who have ...

Previous research indicated that fotagliptin, a dipeptidyl peptidase 4 inhibitor, provided superior glycemic control than placebo in patients with T2D. Researchers conducted a randomized controlled ...

Building wealth starts slow—compounding works best over time, not overnight. Each new crore needs less time: Rs 3–4 crore in 2.5 years, Rs 4–5 crore in 2 years. Rs 5–6 crore takes 1.5 years, Rs 6–7 ...

Tata Steel-owned Neelachal Ispat Nigam Ltd (NINL) has reported an EBITDA of ₹220 crore in Q1FY26. Continuing with its turnaround story, the steelmaker is expecting over ₹1,000 crore in full year ...

Casdatifan plus Cabometyx showed promising activity and tolerability in clear cell renal cell carcinoma patients in the ARC-20 trial. Welireg dosing regimens demonstrated varying response rates, with ...